Hubbry Logo
Aedes aegyptiAedes aegyptiMain
Open search
Aedes aegypti
Community hub
Aedes aegypti
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Aedes aegypti
Aedes aegypti
from Wikipedia

Yellow fever mosquito
Adult
Adult
Larva
Larva
Scientific classification Edit this classification
Kingdom: Animalia
Phylum: Arthropoda
Class: Insecta
Order: Diptera
Family: Culicidae
Genus: Aedes
Subgenus: Stegomyia
Species:
A. aegypti
Binomial name
Aedes aegypti
Subspecies[2][3]
  • Aedes aegypti aegypti
  • Aedes aegypti formosus
Global Aedes aegypti predicted distribution in 2015 (blue=absent, red=present)
Synonyms[1]
  • Culex aegypti Linnaeus in Hasselquist, 1762
  • Culex fasciatus Fabricius, 1805
  • Culex bancrofti Skuse, 1889

Aedes aegypti (/ˈdz/ US: /dz/ or /ˈdz/ from Greek αηδής 'hateful' and /ˈɪpti/ from Latin, meaning 'of Egypt'), sometimes called the Egyptian mosquito, dengue mosquito or yellow fever mosquito, is a mosquito that spreads diseases such as dengue fever, yellow fever, and chikungunya. The mosquito can be recognized by black and white markings on its legs and a marking in the form of a lyre on the upper surface of its thorax. The mosquito is native to north Africa, but is now a common invasive species that has spread to tropical, subtropical, and temperate regions throughout the world.

Biology

[edit]
Male (left) and female (center and right) Ae. aegypti E.A. Goeldi, 1905

Aedes aegypti is a 4-to-7-millimetre-long (532 to 35128 in), dark mosquito which can be recognized by white markings on its legs and a marking in the form of a lyre on the upper surface of its thorax. Females are larger than males. Microscopically females possess small palps tipped with silver or white scales, and their antennae have sparse short hairs, whereas those of males are feathery. Aedes aegypti can be confused with Aedes albopictus without a magnifying glass: the latter have a white stripe on the top of their scutum.[4]

Males live off fruit[5] and only the female bites for blood, which she needs to mature her eggs. To find a host, she is attracted to chemical compounds emitted by mammals, including ammonia,[6] carbon dioxide,[7] lactic acid, and octenol.[8] Scientists at The United States Department of Agriculture (USDA) Agricultural Research Service studied the specific chemical structure of octenol to better understand why this chemical attracts the mosquito to its host and found the mosquito has a preference for "right-handed" (dextrorotatory) octenol molecules.[9] The preference for biting humans is dependent on expression of the odorant receptor AaegOr4.[10] The white eggs are laid separately into water and soon turn black.[5] The larvae initially feed on bacteria and tiny organic particles, growing over a period of weeks through four larval instars until reaching the pupa stage.[4][5][11]

The lifespan of an adult Ae. aegypti is two to four weeks depending on conditions,[4] but the eggs can be viable for over a year in a dry state, which allows the mosquito to re-emerge after a cold winter or dry spell.[5]

Hosts

[edit]

Mammalian hosts include domesticated horses, and feral and wild horses and equids more generally.[12] As of 2009 birds were found to be the best food supply for Ae. aegypti among all taxa.[13]

Distribution

[edit]
Ae. aegypti mosquito distribution in the United States, 2016

Aedes aegypti originated in Africa and was spread to the New World through the slave trade,[14] but is now found in tropical, subtropical and temperate regions[15] throughout the world.[16] Ae. aegypti's distribution has increased in the past two to three decades worldwide, and it is considered to be among the most widespread mosquito species.[17] In 2015, together with a group of colleagues, Khadijetou Lekweiry reported that the species was seen for the first time in Mauritania.[18]

In 2016, Zika virus-capable mosquito populations have been found adapting for persistence in warm temperate climates. Such a population has been identified to exist in parts of Washington, DC, and genetic evidence suggests they survived at least the last four winters in the region. One of the study researchers noted, "...some mosquito species are finding ways to survive in normally restrictive environments by taking advantage of underground refugia".[19] As the world's climate becomes warmer, the range of Aedes aegypti and a hardier species originating in Asia, the tiger mosquito Aedes albopictus, which can expand its range to relatively cooler climates, will inexorably spread north and south. Sadie Ryan of the University of Florida was the lead author in a 2019 study that estimated the vulnerability of naïve populations in geographic regions that currently do not harbor vectors i.e., for Zika in the Old World. Ryan's co-author, Georgetown University's Colin Carlson remarked, "Plain and simple, climate change is going to kill a lot of people."[20] As of 2020, the Northern Territory Government Australia and the Darwin City Council have recommended tropical cities initiate rectification programs to rid their cities of potential mosquito breeding stormwater sumps.[21] A 2019 study found that accelerating urbanization and human movement would also contribute to the spread of Aedes mosquitoes.[22]

In continental Europe, Aedes aegypti is not established but it has been found in localities close to Europe such as the Asian part of Turkey.[23] However, a single adult female specimen was found in Marseille (Southern France) in 2018. On the basis of a genetic study and an analysis of the movements of commercial ships, the origin of the specimen could be traced as coming from Cameroon, in Central Africa.[23]

Genomics

[edit]

In 2007, the genome of Aedes aegypti was published, after it had been sequenced and analyzed by a consortium including scientists at The Institute for Genomic Research (now part of the J. Craig Venter Institute), the European Bioinformatics Institute, the Broad Institute, and the University of Notre Dame. The effort in sequencing its DNA was intended to provide new avenues for research into insecticides and possible genetic modification to prevent the spread of virus. This was the second mosquito species to have its genome sequenced in full (the first was Anopheles gambiae). The published data included the 1.38 billion base pairs containing the insect's estimated 15,419 protein-encoding genes. The sequence indicates the species diverged from Drosophila melanogaster (the common fruit fly) about 250 million years ago, and Anopheles gambiae and this species diverged about 150 million years ago.[24][25] Matthews et al., 2018 finds A. aegypti to carry a large and diverse number of transposable elements. Their analysis suggests this is common to all mosquitoes.[26]

Vector of disease

[edit]

Aedes aegypti is a vector for transmitting numerous pathogens. According to the Walter Reed Biosystematics Units as of 2022,[27] it is associated with the following 54 viruses and two species of Plasmodium:

Aino virus (AINOV), African horse sickness virus (AHSV), Bozo virus (BOZOV), Bussuquara virus (BSQV), Bunyamwera virus (BUNV), Catu virus (CATUV), Chikungunya virus (CHIKV), Chandipura vesiculovirus (CHPV), Cypovirus (unnamed), Cache Valley virus (CVV), Dengue virus (DENV), Eastern equine encephalitis virus (EEEV), Epizootic hemorrhagic disease virus (EHDV), Guaroa virus (GROV), Hart Park virus (HPV), Ilheus virus (ILHV), Irituia virus (IRIV), Israel Turkey Meningoencephalitis virus (ITV), Japanaut virus (JAPV), Joinjakaka (JOIV), Japanese encephalitis virus (JBEV), Ketapang virus (KETV), Kunjin virus (KUNV), La Crosse virus (LACV), Mayaro virus (MAYV), Marburg virus (MBGV), Marco virus (MCOV), Melao virus (MELV), Marituba virus (MTBV), Mount Elgon bat virus (MEBV), Mucambo virus (MUCV), Murray Valley encephalitis virus (MVEV), Navarro virus (NAVV), Nepuyo virus (NEPV), Nola virus (NOLV), Ntaya virus (NTAV), Oriboca virus (ORIV), Orungo virus (ORUV), Restan virus (RESV), Rift Valley fever virus (RVFV), Semliki Forest virus (SFV), Sindbis virus (SINV), Tahyna virus (TAHV), Tsuruse virus (TSUV), Tyuleniy virus (TYUV), Venezuelan equine encephalitis virus (VEEV), Vesicular stomatitis virus (Indiana serotype), Warrego virus (WARV), West Nile virus (WNV), Wesselsbron virus (WSLV), Yaounde virus (YAOV), Yellow fever virus (YFV), Zegla virus (ZEGV), Zika virus, as well as Plasmodium gallinaceum and Plasmodium lophurae.

This mosquito also mechanically transmits some veterinary diseases. In 1952 Fenner et al., found it transmitting the myxoma virus between rabbits[28] and in 2001 Chihota et al., the lumpy skin disease virus between cattle.[28][29]

The yellow fever mosquito can contribute to the spread of reticular cell sarcoma among Syrian hamsters.[30]

Bite prevention methods

[edit]

The Centers for Disease Control and Prevention traveler's page on preventing dengue fever suggests using mosquito repellents that contain DEET (N, N-diethylmetatoluamide, 20% to 30%). It also suggests:

  1. Although Aedes aegypti mosquitoes most commonly feed at dusk and dawn, indoors,[31] in shady areas, or when the weather is cloudy, "they can bite and spread infection all year long and at any time of day."[32]
  2. Once a week, scrub off eggs sticking to wet containers, seal or discard them. The mosquitoes prefer to breed in areas of stagnant water, such as flower vases, uncovered barrels, buckets, and discarded tires, but the most dangerous areas are wet shower floors and toilet tanks, as they allow the mosquitos to breed in the residence. Research has shown that certain chemicals emanating from bacteria in water containers stimulate the female mosquitoes to lay their eggs. They are particularly motivated to lay eggs in water containers that have the correct amounts of specific fatty acids associated with bacteria involved in the degradation of leaves and other organic matter in water. The chemicals associated with the microbial stew are far more stimulating to discerning female mosquitoes than plain or filtered water in which the bacteria once lived.[33]
  3. Wear long-sleeved clothing and long pants when outdoors during the day and evening.
  4. Use mosquito netting over the bed if the bedroom is not air conditioned or screened, and for additional protection, treat the mosquito netting with the insecticide permethrin.

Insect repellents containing DEET (particularly concentrated products) or p-menthane-3,8-diol (from lemon eucalyptus) were effective in repelling Ae. aegypti mosquitoes, while others were less effective or ineffective in a scientific study.[34] The Centers for Disease Control and Prevention article on "Protection against Mosquitoes, Ticks, & Other Arthropods" notes that "Studies suggest that concentrations of DEET above approximately 50% do not offer a marked increase in protection time against mosquitoes; DEET efficacy tends to plateau at a concentration of approximately 50%".[35] Other insect repellents recommended by the CDC include Picaridin (KBR 3023/icaridin), IR3535, and 2-undecanone.[36]

Population control efforts

[edit]

Insecticides

[edit]

Pyrethroids are commonly used.[37] This widespread use of pyrethroids and DDT has caused knockdown resistance (kdr) mutations. Almost no research has been done on the fitness implications. Studies by Kumar et al., 2009 on deltamethrin in India, Plernsub et al., 2013 on permethrin in Thailand, by Jaramillo-O et al., 2014 on λ-cyhalothrin in Colombia, by Alvarez-Gonzalez et al., 2017 on deltamethrin in Venezuela, are all substantially confounded. As of 2019, understanding of selective pressure under withdrawal of insecticide is hence limited.[37]

Genetic modification

[edit]

Ae. aegypti has been genetically modified to suppress its own species in an approach similar to the sterile insect technique, thereby reducing the risk of disease. The mosquitoes, known as OX513A, were developed by Oxitec, a spinout of Oxford University. Field trials in the Cayman Islands,[38] in Juazeiro,[39][40] Brazil,[38] by Carvalho et al., 2015,[39][40] and in Panama[38] by Neira et al., 2014[39] have shown that the OX513A mosquitoes reduced the target mosquito populations by more than 90%. This mosquito suppression effect is achieved by a self-limiting gene that prevents the offspring from surviving. Male modified mosquitoes, which do not bite or spread disease, are released to mate with the pest females. Their offspring inherit the self-limiting gene and die before reaching adulthood—before they can reproduce or spread disease. The OX513A mosquitoes and their offspring also carry a fluorescent marker for simple monitoring. To produce more OX513A mosquitoes for control projects, the self-limiting gene is switched off (using the Tet-Off system) in the mosquito production facility using an antidote (the antibiotic tetracycline), allowing the mosquitoes to reproduce naturally. In the environment, the antidote is unavailable to rescue mosquito reproduction, so the pest population is suppressed.[41]

The mosquito control effect is nontoxic and species-specific, as the OX513A mosquitoes are Ae. aegypti and only breed with Ae. aegypti. The result of the self-limiting approach is that the released insects and their offspring die and do not persist in the environment.[42][43]

In Brazil, the modified mosquitoes were approved by the National Biosecurity Technical Commission for releases throughout the country. Insects were released into the wild populations of Brazil, Malaysia, and the Cayman Islands in 2012.[44][45] In July 2015, the city of Piracicaba, São Paulo, started releasing the OX513A mosquitoes.[46][47] In 2015, the UK House of Lords called on the government to support more work on genetically modified insects in the interest of global health.[48] In 2016, the United States Food and Drug Administration granted preliminary approval for the use of modified mosquitoes to prevent the spread of the Zika virus.[49]

Another proposed method consists in using radiation to sterilize male larvae so that when they mate, they produce no progeny.[50] Male mosquitoes do not bite or spread disease.

Using CRISPR/Cas9 based genome editing to engineer the genome of Aedes aegypti genes like ECFP (enhanced cyan fluorescent protein), Nix (male-determining factor gene), Aaeg-wtrw (Ae. aegypti water witch locus), Kmo (kynurenine 3-monoxygenase), loqs (loquacious), r2d2 (r2d2 protein), ku70 (ku heterodimer protein gene) and lig4 (ligase4) were targeted to modify the genome of Aedes aegypti. The new mutant will become incapable of pathogen transmission or result in population control.[51]

Infection with Wolbachia

[edit]

In 2016 research into the use of a bacterium called Wolbachia as a method of biocontrol was published showing that invasion of Ae. aegypti by the endosymbiotic bacteria allows mosquitos to be resistant to certain arboviruses such as dengue fever and Zika virus strains currently circulating.[52][53][54] In 2017 Alphabet, Inc. started the Debug Project to infect males of this species with Wolbachia bacteria, interrupting the reproductive cycle of these animals.[55]

Fungus infection

[edit]

Fungal species Erynia conica (from the family Entomophthoraceae) infects (and kills) two types of mosquitos: Aedes aegypti and Culex restuans. Studies on the fungus have been carried out on its potiential use as a biological control of the mosquitos.[56]

Taxonomy

[edit]

The species was first named (as Culex aegypti) in 1757 by Fredric Hasselquist in his treatise Iter Palaestinum.[57] Hasselquist was provided with the names and descriptions by his mentor, Carl Linnaeus. This work was later translated into German and published in 1762 as Reise nach Palästina.[58]

Ae. aegypti feeding on a human

To stabilise the nomenclature, a petition to the International Commission on Zoological Nomenclature was made by P. F. Mattingly, Alan Stone, and Kenneth L. Knight in 1962.[59] It also transpired that, although the name Aedes aegypti was universally used for the yellow fever mosquito, Linnaeus had actually described a species now known as Aedes (Ochlerotatus) caspius.[59] In 1964, the commission ruled in favour of the proposal, validating Linnaeus' name, and transferring it to the species for which it was in general use.[60]

The yellow fever mosquito belongs to the tribe Aedini of the dipteran family Culicidae and to the genus Aedes and subgenus Stegomyia. According to one recent analysis, the subgenus Stegomyia of the genus Aedes should be raised to the level of genus.[61] The proposed name change has been ignored by most scientists;[62] at least one scientific journal, the Journal of Medical Entomology, has officially encouraged authors dealing with aedile mosquitoes to continue to use the traditional names, unless they have particular reasons for not doing so.[63] The generic name comes from the Ancient Greek ἀηδής, aēdēs, meaning "unpleasant"[64] or "odious".

Subspecies

[edit]

Two subspecies are commonly recognized:

  • Aedes aegypti subsp. aegypti[2][3]
  • Aedes aegypti subsp. formosus[2][3]

This classification is complicated by the results of Gloria-Soria et al., 2016. Although confirming the existence of these two major subspecies, Gloria-Sora et al. finds greater worldwide diversity than previously recognized and a large number of distinct populations separated by various geographic factors.[2][3] Aedes aegypti formosus is found in natural habitats such as forests, while Aedes aegypti aegypti has adapted to urban domestic habitats.[65]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
(Linnaeus, 1762) is a small species in the family Culicidae, distinguished by its dark body with white lyre-shaped markings on the and banded legs, and it functions as the primary vector for arboviruses causing dengue, chikungunya, Zika, and in humans. This anthropophilic species preferentially bites humans during daylight hours, particularly in the morning and late afternoon, and females require blood meals to develop eggs. Native to tropical and subtropical , its range has expanded globally through human-mediated dispersal via trade and travel, establishing populations in urban and peri-urban areas across the , , and beyond where it exploits artificial water-holding containers like tires, flower pots, and discarded receptacles for breeding. The mosquito's close association with human dwellings facilitates efficient pathogen transmission, contributing to recurrent epidemics of vector-borne diseases that affect millions annually, with control challenged by resistance and climatic factors favoring its proliferation.

Taxonomy and Systematics

Classification and Etymology

Aedes aegypti is classified in the order Diptera, family Culicidae, genus Aedes, species Aedes aegypti (Linnaeus, 1762). The species was originally described by Carl Linnaeus in his 1762 work Fauna Suecica under the name Culex aegypti, reflecting its initial placement in the genus Culex. In 1818, Johann Wilhelm Meigen transferred it to the genus Aedes, a reclassification based on morphological distinctions such as the scaling on the thorax and legs, which separate Aedes from Culex. The etymology of the binomial name traces to ancient roots: Aedes derives from the Greek aēdēs (αηδής), meaning "unpleasant" or "hateful," alluding to the irritating bites of mosquitoes in this genus. The specific epithet aegypti comes from Latin, denoting "of Egypt," as early European naturalists associated abundant populations with that region following observations during explorations and trade routes. Phylogenetically, Aedes aegypti traces its origins to , where it diverged from a sylvatic, forest-dwelling (A. aegypti formosus) approximately 10,000–15,000 years ago, adapting to human environments through domestication-like processes. This African lineage distinguishes it from congeners like Aedes albopictus, an of Asian provenance with broader host preferences and cold tolerance enabling temperate spread.

Subspecies and Genetic Variants

Aedes aegypti comprises two primary subspecies: the domestic Aedes aegypti aegypti (Aaa), which is highly anthropophilic and associated with human-modified environments, and the sylvatic Aedes aegypti formosus (Aaf), which inhabits forested areas and feeds primarily on nonhuman primates. Aaa originated in but has spread globally as an invasive vector, while Aaf represents the ancestral form confined largely to . The exhibit genetic differentiation, with Aaf displaying greater ancestral polymorphism that contributed to standing variation later fixed in Aaa through . Whole-genome sequencing of 1206 samples from 73 locations confirmed distinct genomic signatures between the forms, including fixed differences in frequencies, yet revealed their reproductive compatibility and evidence of historical hybridization, particularly in African sympatric zones. markers have also identified moderate genetic structuring, aiding differentiation in population studies. Debates persist on the taxonomic validity of these , with morphological traits (e.g., scale patterns and body size) historically used for distinction but increasingly challenged by genomic data emphasizing clinal variation over discrete boundaries. Proponents argue for retaining subspecies status due to ecological and behavioral divergence with epidemiological implications, such as differing vector competencies, while critics favor designations to reflect . Recent analyses, however, support recognition of Aaa and Aaf for tracking invasion dynamics and targeting control, as hybridization does not fully erode genetic markers essential for identification.

Morphology and Physiology

Physical Characteristics

Adult Aedes aegypti mosquitoes are small, with body lengths typically ranging from 4 to 7 mm. The body is covered in scales, predominantly black with distinctive white or silvery-white scale patches that form characteristic patterns for species identification. On the thorax, these white scales create a lyre-shaped marking, consisting of a median longitudinal line flanked by two curved lines, distinguishing A. aegypti from related species like Aedes albopictus, which exhibits longitudinal stripes instead. The legs are slender and primarily black, adorned with white scales forming transverse bands at the joints, particularly prominent on the tarsi, aiding in rapid visual differentiation from congeners lacking such banding. The abdomen features scattered white scales laterally and sometimes dorsally, creating a somewhat speckled appearance against the dark background. Wings are uniformly covered in dark scales without notable patterns. Sexual dimorphism is pronounced in several traits relevant to identification. Females are generally larger than males and possess a long, straight suited for piercing , with short maxillary palps that are not bushy. Males exhibit bushy, plumose antennae with dense whorls of scales for enhanced sensory detection, and their maxillary palps are elongated and clubbed at the tip. Both sexes have large compound eyes and three ocelli, contributing to their sensory apparatus for navigating environments.

Life Cycle Stages

Aedes aegypti undergoes holometabolous , featuring distinct , larval (four instars), pupal, and stages. Eggs are laid by gravid females in small batches or individually on substrates above standing water following a , with each female producing approximately 100-200 eggs per gonotrophic cycle. These eggs exhibit high resistance, remaining viable for up to 8-15 months or longer under dry conditions before hatching upon submersion in water. Embryonic development requires 2-3 days at optimal temperatures of 25-30°C. Larvae develop aquatically as filter-feeders on microorganisms and organic detritus, progressing through four instars in durations totaling 5-7 days under tropical conditions (25-30°C), with development accelerating at higher temperatures within the viable range of 16-36°C but declining above 35°C due to increased mortality. They are vulnerable to temperatures outside 20-30°C, where survival and growth rates diminish. The pupal stage, also aquatic and non-feeding, lasts about 2 days at 25-30°C, serving as a transitional phase for adult formation. Adult emergence follows, with females seeking blood meals to support ; the gonotrophic cycle spans 3-4 days. The complete generation time from egg to reproductive measures 7-10 days in warm tropical settings, driven by temperature-dependent rates that shorten durations up to an optimum of 25-30°C.

Behavior and Ecology

Host Preferences and Biting Behavior

Aedes aegypti displays a pronounced anthropophilic tendency, preferentially selecting humans as hosts over other mammals or birds. This behavior is mediated by the integration of multiple sensory cues, including exhaled carbon dioxide (CO₂), which sensitizes the mosquito's olfactory system to detect skin-derived odors and body heat signatures from potential hosts. Visual contrasts further refine host location once initial cues activate seeking flight. Studies confirm that human-specific odors can elicit landing responses even without concurrent visual or thermal stimuli, underscoring the primacy of chemical attractants in host discrimination. Female A. aegypti exhibit diurnal activity, with peak host-seeking occurring in the early morning (around 07:00–08:00) and late afternoon (17:00–18:00), aligning with periods of heightened outdoor exposure in tropical environments. Blood meals are essential for egg maturation, and females often require multiple feeds per gonotrophic cycle to optimize reproductive output, particularly in nutrient-variable urban settings. Post-feeding, adults predominantly engage in endophilic resting indoors, favoring shaded, humid microhabitats below 1.5 meters in height, such as under furniture or along walls. The species' limited dispersal capability, with typical flight ranges of 50–100 meters, constrains host access to proximate urban human populations, reinforcing its adaptation to peridomestic environments. Mark-release-recapture data indicate an average dispersal distance of approximately 106 meters, though wind-assisted movement can extend this sporadically. This short-range mobility favors dense human settlements where breeding sites and hosts remain closely coupled.

Habitat and Breeding Sites

thrives in human-modified environments, particularly urban and peri-urban settings where it exploits artificial water-holding as primary breeding sites. Unlike its sylvatic ancestors that utilized natural phytotelmata such as tree holes, this species has adapted to domestic habitats, favoring small, artificial accumulations of including discarded tires, flower pots, buckets, water storage tanks, and vases. These habitats provide stagnant essential for egg hatching and larval development, with females ovipositing on container walls above the to protect eggs from . The mosquito exhibits notable tolerance for sub-optimal , including polluted and organically enriched conditions that would deter many other , enabling proliferation in resource-limited urban microhabitats. Optimal breeding occurs in partially shaded sites with temperatures between 25–30°C, where remains sufficiently warm for rapid larval development yet avoids lethal overheating; exposure to direct sunlight can elevate temperatures beyond 35°C, reducing larval survival. Larval density significantly influences outcomes, as high crowding in containers leads to for resources, resulting in smaller adult sizes and lower overall survival rates. This adaptation to anthropogenic niches underscores A. aegypti's peridomestic , distinguishing it from more floodwater-dependent congeners.

Genomic Features

Genome Structure and Sequencing

The genome of Aedes aegypti spans approximately 1.38 gigabase pairs (Gbp), making it substantially larger than that of Drosophila melanogaster (approximately 180 megabase pairs), with estimates ranging from 1.25 to 1.4 Gbp across assemblies. This size is characterized by high repetitive content, including up to 65% composed of transposable elements (TEs) and other repeats, which has historically complicated assembly efforts due to the proliferation of interspersed repeats and retrotransposons. Initial sequencing efforts produced a draft assembly in 2007 (AaegL1), a haploid reference with 1.4 Gbp across 4,523 scaffolds and 7.6× coverage, derived from the strain. Subsequent improvements addressed fragmentation and repeat resolution; for instance, the AaegL3 assembly in 2007 struggled with the repetitive nature but laid groundwork for research. More recent diploid phased assemblies, such as AaegL5.0 (2018), incorporated long-read technologies to enhance contiguity, spanning contigs NIGP01000001 to NIGP01002309. Chromosome-scale de novo assemblies emerged in the late , leveraging interaction data to scaffold the three-chromosome (1.39 Gbp for the strain in 2022), improving upon prior drafts by anchoring repeats and enabling better structural annotation. Gene annotation in these assemblies identifies around 15,419 protein-coding genes, with transcriptional evidence supporting approximately 80% via multiple methods, including clusters involved in immunity pathways and olfactory receptors (e.g., gustatory and odorant receptors distributed across chromosomes 2 and 3). These features underscore the genome's complexity as a vector resource.

Genetic Diversity and Adaptations

Invasive populations of Aedes aegypti exhibit reduced attributable to founder effects and bottlenecks during range expansions, such as the colonization of the , which resulted in only minor overall reductions in diversity compared to ancestral African populations. Despite these bottlenecks, sufficient standing persists, enabling rapid local through selection on pre-existing polymorphisms rather than de novo mutations. This pattern is evident in comparative genomic analyses, where invasive lineages derive adaptive signatures from ancestral forest-form (A. aegypti formosus) variation, facilitating shifts to urban ecologies without substantial loss of adaptive potential. A key adaptation in contemporary populations involves insecticide resistance, primarily mediated by knockdown resistance (kdr) mutations in the voltage-gated sodium channel (VGSC) gene. Common alleles include V1016G/I, F1534C, and more recently identified variants like F1534L, which confer pyrethroid resistance by altering channel gating and reducing insecticide binding affinity. Global surveys, including those from India and Brazil as of 2025, reveal high frequencies of these mutations (e.g., up to 90% homozygosity in resistant strains), often linked to intronic haplotypes that enhance survival under selection pressure from vector control programs. These resistance loci show signatures of recent selective sweeps, with elevated linkage disequilibrium indicating strong, ongoing positive selection across continents. Urban adaptations, including preferences for container breeding in anthropogenic water sources, are associated with genome-wide selective sweeps at loci influencing chemosensory, metabolic, and developmental traits. Phylogenetic and differentiation analyses of global populations identify hundreds of regions under selection, particularly in domestic forms (A. aegypti aegypti), where sweeps target genes for egg desiccation resistance and larval habitat tolerance, traits pre-adapted from standing variation in humid African ancestors. Local environmental adaptation signals, such as those tied to temperature and vegetation gradients, further demonstrate how polymorphisms in regulatory and neuronal genes enable fine-tuned responses to urban heat islands and breeding site availability, with FST outliers concentrated in metabolic pathways. These genomic patterns underscore A. aegypti's capacity for exaptation, where ancestral variation fuels invasion success without requiring novel genetic innovation.

Distribution and Invasion Dynamics

Historical Origins and Native Range

Aedes aegypti originated in , where its ancestral sylvatic form, known as Aedes aegypti formosus, inhabits forested ecotones and relies on natural breeding sites such as tree holes for oviposition and feeds primarily on non-human mammals and birds. This pre-domestic lineage represents the species' evolutionary cradle, with genetic evidence from population genomics confirming diversification within tropical African habitats prior to human-mediated adaptations. Sylvatic populations persist today in regions like and Kenya, exhibiting higher genetic diversity indicative of long-term endemicity compared to derived forms elsewhere. The transition to the domestic form, Aedes aegypti aegypti, occurred through specialization on human hosts and artificial containers, with genomic dating estimating divergence from sylvatic ancestors around 5,000 years ago at the close of the , aligning with early human settlement patterns in . Whole-genome sequencing of over 1,200 specimens across and beyond reveals that invasive domestic lineages form a monophyletic rooted in sub-Saharan genetic pools, underscoring a singular African origin rather than multiple independent emergences. These findings, drawn from 2025 studies, highlight ancestral polymorphisms in African samples that predate global dispersal, including alleles for container breeding absent in distantly related Asian Aedes species like Aedes albopictus. Unlike Aedes taxa with Asian provenance, such as A. albopictus, which exhibit separate evolutionary trajectories tied to Southeast Asian forests, A. aegypti's native range remained confined to African tropics and adjacent islands before , as evidenced by phylogeographic reconstructions showing no pre-colonial from Eurasian clades. This distinction is reinforced by mitochondrial and nuclear markers tracing basal lineages exclusively to continental and peri-Saharan , predating the formation of the current Saharan barrier approximately 4,000–6,000 years ago.

Global Spread and Current Distribution

Aedes aegypti maintains established populations primarily in tropical and subtropical regions worldwide, encompassing much of the , , , and . In the , the species is widespread from the —where it has re-established in states including , , , and —throughout Central and to northern . In , populations persist in tropical zones such as and other West African areas, though absent from arid Saharan regions. Asian distribution includes extensive coverage in , , and parts of the , while in , it occupies Pacific islands and . The mosquito remains largely absent from temperate zones, including most of , where cold winters preclude sustained populations despite sporadic introductions. European surveillance as of June 2025 documents limited regional presence, confined to southern locales like parts of the coast and Mediterranean islands, but without broad continental establishment. Similarly, higher-altitude and arid areas globally lack persistent colonies due to unsuitable climates. Recent empirical detections, such as larvae and adults at bus stations in Bogotá, , during December 2023–January 2024, highlight ongoing surveillance needs in transport hubs, though these do not indicate new establishments. Historical eradication efforts in the mid-20th century temporarily eliminated A. aegypti from regions like the and parts of , but subsequent re-invasions via shipping and trade have restored its presence in endemic areas. Current mapping relies on field surveillance and larval surveys rather than predictive models, confirming its core without expansion into polar or extensively temperate latitudes.

Drivers of Expansion

The expansion of Aedes aegypti beyond its native African range has been primarily driven by human-mediated dispersal mechanisms, including and , which facilitate the unintentional of eggs and immature stages in commodities such as used tires and water-holding containers. Historical records indicate that the species was introduced to the in the via slave ships from , rapidly establishing populations along coastal ports and spreading inland through maritime commerce well before the onset of modern anthropogenic warming in the late . This early colonization, documented through genetic and epidemiological evidence of serial founder events, underscores that global dissemination predates significant climatic shifts, challenging narratives overemphasizing temperature as the initiating factor. Urbanization exacerbates local proliferation by generating abundant artificial breeding sites, such as discarded containers and inadequate systems prevalent in densely populated, low-income areas with deficient . Empirical studies correlate A. aegypti abundance more strongly with socioeconomic indicators like levels and poor than with ambient alone, as urban human behaviors—such as storing water in open vessels—create persistent oviposition opportunities independent of thermal thresholds. For instance, rapid unplanned urban growth in tropical regions amplifies infestation risks through increased human-mosquito contact and suitability, rather than solely via expanded niches. While rising temperatures may secondarily prolong transmission seasons by optimizing extrinsic incubation periods and larval development rates within established ranges, modeling of invasion dynamics reveals that human movement patterns quantitatively predict range shifts better than climatic variables, with globalization enabling jumps into previously unsuitable areas. This human-centric causality is evident in intracontinental spreads, such as reintroductions via tire trade, where socioeconomic deficits in vector surveillance sustain populations post-arrival. Overreliance on climate projections for forecasting expansion risks understates the primacy of preventable anthropogenic vectors, as pre-20th-century distributions already spanned subtropical latitudes without equivalent warming.

Disease Vector Role

Primary Pathogens Transmitted

Aedes aegypti primarily transmits arboviruses within the genera Flavivirus and Alphavirus, including dengue virus (DENV) encompassing four serotypes (DENV-1 to DENV-4), Zika virus (ZIKV), yellow fever virus (YFV), and chikungunya virus (CHIKV). These pathogens establish persistent infections in the mosquito midgut and salivary glands, enabling lifelong transmission potential following an extrinsic incubation period. Vector competence—the ability to acquire, maintain, and transmit a —varies by serotype or strain, population genetics, and extrinsic factors such as . For DENV, competence rates in infections often exceed 50% for multiple serotypes, though dissemination efficiency can differ, with DENV-2 frequently showing higher transmissibility in certain strains. Similar patterns hold for ZIKV, CHIKV, and YFV, where African strains of YFV exhibit lower competence compared to American lineages in some cohorts. The extrinsic incubation period for these viruses typically spans 8-12 days post-infection under temperatures of 25-30°C, during which the must traverse the barrier, replicate in secondary tissues, and invade salivary glands. Shorter periods (as low as 7 days) occur at higher temperatures, accelerating dissemination but potentially reducing overall vector capacity due to shortened lifespan. Field-derived minimum infection rates, calculated from pooled mosquito dissections or molecular screening, indicate natural exposure to these pathogens, often ranging from 0.1% to 5% during interepidemic periods and rising to 10% or higher amid outbreaks. In a 2021 study from , among arbovirus-positive Aedes aegypti, CHIKV accounted for 77.7% of infections, DENV for 11.4%, and ZIKV for 9%, reflecting overdispersed distribution where a minority of mosquitoes harbor high viral loads. Co-infections with multiple viruses, such as DENV and CHIKV, can elevate overall infection prevalence to near 100% in exposed cohorts. Unlike anophelines, Aedes aegypti lacks competence for Plasmodium parasites and does not transmit malaria, avian or otherwise, due to incompatible midgut environments and immune responses blocking ookinete development. Laboratory evidence supports potential competence for secondary alphaviruses like Mayaro virus (MAYV), with dissemination rates up to 80% under stress conditions, though field transmission remains negligible relative to core pathogens.

Transmission Mechanisms

Aedes aegypti primarily transmits arboviruses such as dengue, Zika, chikungunya, and yellow fever viruses through biological transmission, wherein the pathogen undergoes replication within the mosquito vector before being inoculated into a new host. During a blood meal from a viremic vertebrate host, the virus is ingested and initially replicates in the mosquito's midgut epithelial cells, overcoming a midgut infection barrier; successful dissemination to the hemocoel follows, after which the virus infects and replicates in the salivary glands, surmounting a salivary gland escape barrier. This extrinsic incubation period (EIP), the time from ingestion to infectivity, typically spans 8–12 days for dengue virus at temperatures of 27–30°C, though it shortens at higher temperatures (e.g., 7 days at 35°C) and lengthens at cooler ones, influencing transmission dynamics. Once the salivary glands are infected, the mosquito injects virus-laden into the skin of a subsequent host during probing and feeding, facilitating efficient biological transmission that can persist for the mosquito's remaining lifespan of up to one month. Mechanical transmission—wherein virus is carried externally on the without replication—has been demonstrated experimentally for immediately after feeding on infected hosts, potentially contributing marginally during outbreaks with high densities. However, under natural conditions, mechanical transmission of or viruses by Aedes aegypti is highly unlikely due to rapid viral inactivation on the and the vector's preference for multiple probing events. Transmission efficiency hinges causally on host levels, with higher viral titers in the correlating to increased infection rates and dissemination success; for instance, dengue cases with peak exceeding 10^6–10^8 genome equivalents per milliliter pose greater transmission risk to vectors. occurs predominantly when multiple feed on the same viremic host, amplifying spread without requiring inter- contact. , from infected females to offspring via eggs, occurs at low rates insufficient for maintenance—e.g., filial infection rates for in field-collected A. aegypti range from 0% to about 7%, and even lower for dengue—thus playing a minor role compared to horizontal cycles.

Epidemiological Burden

Aedes aegypti-transmitted dengue imposes the predominant epidemiological burden among arboviral diseases, with over 13 million cases and more than 9,600 deaths reported globally in 2024, marking a substantial surge from approximately 6.5 million cases in 2023. This escalation reflects intensified transmission cycles driven by the mosquito's urban adaptation, though Zika and remain episodic with lower incidence; for instance, chikungunya cases in the reached about 186,000 by mid-2024, concentrated in , while Zika reports were negligible without sustained outbreaks. Regional hotspots center on the and , where the alone accounted for over 13 million dengue cases in 2024, fueled by hyperendemic circulation in countries like and . contributes significantly to the global tally, with cyclical epidemics exacerbating the load amid dense urban populations. However, surveillance limitations result in underreporting, as many endemic areas lack robust detection systems, underestimating the true incidence by factors of 10 to 100 in resource-poor settings. The economic toll of dengue, largely attributable to Aedes aegypti, is estimated at $8.9 billion annually worldwide based on 2013 data, encompassing direct medical costs, productivity losses, and expenditures, with costs likely higher amid recent surges. Urban poor communities bear disproportionate vulnerability due to inadequate fostering larval habitats in stagnant containers, amplifying transmission in slums and informal settlements where access to care is limited.

Control Strategies

Chemical and Physical Controls

Chemical control of Aedes aegypti primarily involves s targeting immature stages and adulticides for flying adults, though widespread resistance has reduced efficacy in many regions. Temephos, an , has been widely applied to breeding sites such as water containers, but resistance has developed in populations across , , and other areas, with susceptibility reductions up to 7.83-fold after prolonged exposure. Pyrethroids, including and , dominate adulticide use, comprising over 30% of global applications against the , yet resistance is prevalent due to mechanisms like enhanced enzymes. of classes is recommended to mitigate resistance, as empirical data show operational failures where single-class reliance persists. Space spraying via ultra-low volume (ULV) adulticiding offers temporary knockdown in outbreak responses, achieving up to 99% immediate biting reduction in some trials, but efficacy wanes within 1-5 days and is limited in dense urban environments where A. aegypti preferentially rests indoors on surfaces inaccessible to outdoor sprays. Urban challenges include mosquito behavior favoring shaded, hidden refugia and logistical barriers to comprehensive coverage, necessitating integration with other tactics for sustained impact. Physical controls emphasize source reduction through elimination or treatment of larval habitats, such as discarding artificial containers that hold stagnant water, proving highly effective when combined with efforts. Historical campaigns in the during the 1950s-1960s, coordinated by the , eradicated A. aegypti from 18 countries by 1962 using spraying alongside rigorous source reduction, demonstrating near-total suppression in compliant areas. Modern evaluations confirm source reduction lowers pupal indices by 71% or more in intervention groups, outperforming chemical-only approaches in resource-limited urban settings.

Biological Interventions

Wolbachia pipientis, an endosymbiotic bacterium, reduces Aedes aegypti vector competence by inhibiting replication of dengue, Zika, , and viruses within infected mosquitoes. Stable cytoplasmic incompatibility ensures preferential spread of -infected females, leading to population replacement. Field releases involve mass rearing and dispersal of infected eggs or adults, achieving establishment rates above 80% in optimized trials when sustained over months. In , , a quasi-experimental deployment from 2016–2017 resulted in 77% fewer virologically confirmed dengue cases and 86% fewer hospitalizations compared to untreated areas, with effects persisting post-intervention due to stable infection prevalence exceeding 70%. Northern , , saw sustained establishment since 2011, correlating with near-elimination of local dengue transmission and annual reductions in notified cases by over 90% in treated zones. By October 2025, programs in , , and reported analogous dengue incidence drops of 50–77%, though variable outcomes in sites like parts of reflect challenges from high mosquito dispersal or incomplete coverage. Entomopathogenic fungi such as Metarhizium anisopliae and infect A. aegypti larvae and adults via cuticle penetration, inducing mycosis and mortality within 3–7 days. Blastospore formulations exhibit higher than conidia, with LT50 values of 2–4 days for adults at 107 spores/mL doses in lab assays, and LC50 for larvae around 1.09 × 105 conidia/mL. Field trials using fungal sprays or auto-dissemination stations in and achieved 50–80% adult mortality in treated sites over 4–6 weeks, but suppression waned due to UV degradation and humidity dependence, limiting standalone efficacy without integration. Predatory agents targeting larvae, including fish like Gambusia affinis and copepods such as Mesocyclops aspericornis, consume up to hundreds of larvae daily in compatible habitats. Stocking trials in rural tires or ponds yield 70–90% larval reduction, with copepods persisting in semi-urban containers at densities of 10–20 individuals/L. Urban constraints—prevalent small, transient artificial oviposition sites like flower pots—hinder colonization, as predators fail to establish in volumes under 1 L or amid frequent disturbances, resulting in inconsistent field suppression below 50% in city trials. tadpoles show similar limitations from low container survival and variable predation rates. Overall, while delivers durable, scalable reductions in and , fungal and predatory methods offer supplementary, site-specific control hampered by Aedes' urban breeding ecology.

Genetic and Sterile Insect Techniques

The (SIT) for Aedes aegypti involves mass-rearing male mosquitoes, sterilizing them via such as gamma rays or X-rays at doses around 50 Gy to achieve approximately 99% sterility while preserving mating competitiveness, and releasing them to compete with wild males for mates, thereby reducing population fertility over generations. Field applications have demonstrated efficacy, with sustained releases leading to significant suppression; for instance, in a trial integrating SIT with other measures, no wild eggs were collected in the treatment area after three weeks, indicating near-complete local elimination of breeding. A 2024 review of multiple projects confirmed SIT's role in suppressing A. aegypti populations, though requires optimized to minimize fitness costs. Genetically modified strains complement SIT by incorporating self-limiting transgenes, as in Oxitec's OX513A males, which express a tetracycline-repressible lethal gene causing female offspring to die before maturity in the absence of tetracycline, ensuring non-persistent inheritance while allowing male progeny to propagate the trait temporarily. Releases in Brazil during the 2010s, particularly in Jacobina from 2013 onward, achieved 80-96% suppression of target wild populations over multiple years, with independent monitoring verifying reduced adult mosquito numbers and no evidence of transgene establishment beyond self-limiting effects despite initial debates over trace detections. Similar trials in other sites yielded over 90% reductions, outperforming conventional methods in urban settings. CRISPR/Cas9-based gene drives aim to suppress populations by biasing inheritance of alleles that disrupt female fertility or skew sex ratios toward males, with lab cage trials in A. aegypti showing up to 89% transmission efficiency over generations using confinable split-drive designs to mitigate uncontrolled spread risks. However, transitions to field applications remain constrained by resistance evolution in lab models, variable drive efficiency across genetic backgrounds, and requirements for high release thresholds, limiting deployment to contained settings as of 2025. Genomic surveillance of releases, informed by whole-genome sequencing of over 1,200 A. aegypti samples globally, enables tracking of engineered dynamics amid natural invasions but highlights the need for robust containment to prevent unintended .

Challenges and Controversies in Implementation

Widespread insecticide resistance in Aedes aegypti populations has significantly compromised chemical control strategies, with resistance to pyrethroids documented globally due to mutations such as V410L in the voltage-gated and knockdown resistance (kdr) alleles like F1534C. In regions like and the , resistance extends to organophosphates, carbamates, and multiple classes simultaneously, leading to operational control failures despite intensified spraying. Public concerns over potential health risks from aerosolized insecticides, including respiratory issues and environmental contamination, have further hindered large-scale spraying campaigns, exacerbating reliance on already ineffective methods. Genetically modified (GM) mosquito releases have sparked controversies over transgene persistence and unintended ecological effects. In Jacobina, Brazil, during the 2010s, Oxitec's OX513A strain releases aimed to suppress wild populations, but a 2019 study reported that up to 60% of local A. aegypti carried transgenic DNA fragments, potentially enhancing wild mosquito fitness rather than suppressing it, prompting backlash and retraction demands from dissenting co-authors. Oxitec contested these findings, attributing persistence to non-target monitoring errors, yet the incident highlighted risks of gene flow into non-target populations. Gene drive technologies, intended for population suppression or modification, raise ethical concerns including irreversible ecological disruptions, such as unintended spread to non-target species or loss of biodiversity, with potential for drive failure leading to resistant subpopulations or off-target mutations. Critics argue that overemphasis on advanced technologies like GM insects neglects foundational measures, as A. aegypti proliferation correlates strongly with inadequate and in urban areas, where larvae thrive in artificial containers. Integrated vector management (IVM) programs have empirically failed in various settings due to poor , inconsistent community participation, and insufficient coverage, as seen in French overseas territories where despite decades of efforts, dengue outbreaks persisted owing to lapses in larval habitat elimination. These shortcomings underscore the need for robust regulatory oversight and behavioral interventions to complement technological approaches, rather than substituting for them.

Recent Advances and Projections

Key Genomic and Field Studies

A comprehensive analysis of 1206 whole-genome sequences from Aedes aegypti populations across 73 locations worldwide, published in September 2025, elucidated the mosquito's invasion routes from to the and , linking genetic events to heightened dengue transmission risk in urban settings. This dataset highlighted signatures of positive selection during expansion, including adaptations to novel climates and human-associated environments that facilitate spread. Adaptive genomic studies have identified variants conferring resistance and climate tolerance in invasive A. aegypti populations. A March 2025 investigation of 686 genomes from 14 countries revealed genomic signatures of specialization, including sweeps at chemosensory and metabolic genes, alongside widespread resistance alleles in loci like kdr and targets. Concurrently, analyses of heat tolerance variation demonstrated genetically based standing variation enabling rapid thermal adaptation, with population-level differences in upper lethal temperatures tied to latitude and urbanization gradients. De novo chromosome-scale genome assemblies have enhanced annotation of A. aegypti and related species, improving resolution of transposable elements and regulatory regions implicated in vector competence. A January 2025 effort produced high-contiguity assemblies using long-read sequencing, revealing structural variants absent in prior references and facilitating comparative genomics across Aedes taxa for traits like antiviral immunity. These assemblies correct assembly gaps in earlier drafts, yielding more accurate gene models for over 15,000 protein-coding loci. Field trials and experimental infections in 2025 have quantified dengue virus (DENV) impacts on A. aegypti fitness, showing disseminated infections reduce longevity and fecundity by 20-30% under controlled conditions mimicking endemic zones. Reviews of co-infection dynamics with indicate that while the bacterium blocks DENV replication, viral loads in doubly infected mosquitoes can still impose subtle fitness costs, such as impaired larval development during episodes. These findings underscore ecological feedbacks where prevalence selects for resilient genotypes in field populations.

Impacts of Environmental Changes

Aedes aegypti exhibits optimal immature development rates between 25°C and 32°C, with peak larval and pupal growth observed around 28–30°C in controlled studies measuring development time and across gradients. Above 32°C, development accelerates but and decline sharply, limiting in extreme , while temperatures below 15°C halt development entirely, imposing seasonal constraints in temperate zones. Empirical field data from tropical urban sites corroborate these optima, showing higher larval densities correlating with mean temperatures in the 25–30°C range rather than extrapolative models of warming thresholds. Higher temperatures within the viable range (e.g., 30–35°C) confer a to over in shared habitats, as evidenced by larval experiments where aegypti outcompetes albopictus for resources at elevated temperatures due to faster development and greater tolerance. In contrast, cooler conditions (below 25°C) favor albopictus dominance, explaining asymmetrical displacement patterns in transitional zones like southern U.S. states, where empirical surveys link aegypti persistence to localized urban heat islands rather than broad climatic shifts. Urbanization drives Aedes aegypti expansion more directly than gradual global warming, with field studies in and documenting elevated abundance tied to dense settlements providing artificial breeding sites, independent of anomalies. Historical distribution data reveal spread decoupled from 20th-century warming trends, as introductions via global preceded significant CO2-driven rises, with stable ranges in northern limited by and rather than projected gains. Model-based forecasts of poleward shifts often overestimate empirical realities, where lapses and infrastructure predict local proliferation better than decadal climate signals. Inadequate human water management exacerbates breeding opportunities, as stagnant artificial containers—such as uncovered storage tanks, discarded tires, and unreliable piped supplies—create persistent larval habitats in urban settings, amplifying populations beyond what ambient alone would sustain. Empirical surveys across endemic regions consistently identify these anthropogenic sites as primary producers, with poor correlating to 70–90% of positive breeding collections, underscoring causal primacy of behavioral and infrastructural failures over incremental environmental warming.

Ongoing Global Outbreaks

In 2024, global dengue cases transmitted primarily by Aedes aegypti reached a record high of over 14 million, with more than 10,000 deaths reported, marking a surge exceeding 200% compared to previous years and driven by expanded mosquito ranges and dynamics in endemic regions. The alone accounted for over 13 million cases, including severe outbreaks in , , and , where A. aegypti densities correlated with elevated transmission risks in urban areas like . By early 2025, Pacific Island nations faced intensified outbreaks, with over 16,500 confirmed dengue cases and 17 deaths across countries including , , and , attributed to A. aegypti proliferation amid seasonal rains and travel-linked introductions. In , more than 12,000 clinical diagnoses were recorded by September 2025, prompting emergency responses, while reported 647 confirmed cases by May. These events highlight ongoing vulnerability in island ecosystems, where A. aegypti has detected persistent larval habitats despite interventions. In the United States, travel-associated dengue cases imported by A. aegypti-exposed visitors hit record levels in 2024, with over 745 incidents by mid-year—more than double typical annual figures—primarily from , underscoring risks of local amplification in southern states. Surveillance in during late 2023 to early 2024 confirmed A. aegypti presence at high-altitude sites like bus stations (2,625 m elevation), signaling potential upward range expansion and heightened outbreak potential in non-traditional areas. Meanwhile, Wolbachia-infected A. aegypti deployments have demonstrated up to 77% reduction in local dengue transmission in trial sites like and through 2025, though global outbreaks persist where coverage remains limited. Density models project continued escalation in tropical urban centers absent scaled interventions, based on 2024 trends of serotype cocirculation and climate-influenced vector abundance.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.